Figure 4
From: RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer
Percentages of hypermethylation in various regions (U2–D4) of RASSF2.
Figure 4 | British Journal of Cancer
From: RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer
Percentages of hypermethylation in various regions (U2–D4) of RASSF2.
